Activated charcoal, tablets 250 mg 50 pcs

It has enterosorbent, detoxifying and anti-diarrheal action. It belongs to the group of polyvalent physical and chemical antidotes with high surface activity.

It adsorbs poisons and toxins from gastrointestinal tract before their absorption, including alkaloids, glycosides, barbiturates and other narcotics, salts of heavy metals, toxins of bacterial, plant and animal origin, phenol and hydrocyanic acid derivatives, sulfonamides and gases.

The drug adsorbs excess of certain metabolic products – bilirubin, urea, cholesterol and also endogenous metabolites responsible for the development of endogenous toxicosis.

Pharmacokinetics

It is not absorbed, not broken down, excreted completely through the gastrointestinal tract within 24
hours.

Indications

Exogenous and endogenous intoxications of various origins (as a detoxifying agent). Foodborne toxic infections, dysentery, salmonellosis (with complex treatment).
Poisoning with drugs (psychotropic, sleeping pills, narcotics), alkaloids, salts of heavy metals and other poisons.
Diseases of the gastrointestinal tract, accompanied by dyspepsia and flatulence.
Food and drug allergies.
Hyperbilirubinemia (viral hepatitis and other jaundices) and hyperazotemia (renal failure).
To reduce gas formation in the intestines before ultrasound and x-ray examinations.
In order to prevent chronic intoxication in hazardous industries.

Pharmacological effect

It has an enterosorbing, detoxifying and antidiarrheal effect. Belongs to the group of polyvalent physicochemical antidotes and has high surface activity.

Adsorbs poisons and toxins from the gastrointestinal tract before their absorption, including alkaloids, glycosides, barbiturates and other hypnotics and narcotics, salts of heavy metals, toxins of bacterial, plant, animal origin, derivatives of phenol, hydrocyanic acid, sulfonamides, gases.

The drug also adsorbs an excess of certain metabolic products – bilirubin, urea, cholesterol, as well as endogenous metabolites responsible for the development of endogenous toxicosis.

Pharmacokinetics

Not absorbed, not broken down, excreted completely through the gastrointestinal tract within 24
hours.

Special instructions

When treating intoxications, it is necessary to create an excess of carbon in the stomach (before gastric lavage) and in the intestines (after gastric lavage). Reducing the concentration of carbon in the medium promotes desorption of the bound substance and its absorption (to prevent resorption of the released substance, repeated gastric lavage and administration of carbon are recommended).

The presence of food masses in the gastrointestinal tract requires administration in high doses, since the contents of the gastrointestinal tract are sorbed by carbon and its activity decreases. If poisoning is caused by substances involved in the enterohepatic circulation (cardiac glycosides, indomethacin, morphine and other opiates), charcoal must be used for several days.

When using the drug for more than 10-14 days, prophylactic administration of vitamins and calcium supplements is necessary.

Patients with diabetes mellitus and those on a low-carbohydrate diet
it is necessary to take into account that one tablet of the drug contains about 0.07 g of carbohydrates (0.006 XE).

It is recommended to store in a dry place, away from substances that release gases or vapors into the atmosphere.

Storage in air (especially humid) reduces sorption capacity.

Impact on the ability to drive vehicles and machinery

The use of the drug does not affect the ability to perform potentially dangerous activities
activities requiring increased concentration of attention and speed of psychomotor reactions
(driving vehicles, working with moving mechanisms, working as a dispatcher and
operator).

Active ingredient

Activated carbon

Composition

For one tablet:
Active substance:
activated carbon – 0.25 g.
Excipients (to obtain a tablet weighing 0.32 g):
potato starch – 0.054 g,
sucrose (sugar) – 0.016 g.

Pregnancy

It is possible to use the drug during pregnancy and breastfeeding if the expected benefit to the mother outweighs the potential risk to the fetus and child. You should consult your doctor.

Contraindications

Hypersensitivity to the components of the drug, ulcerative lesions of the gastrointestinal tract (including gastric and duodenal ulcers, ulcerative colitis), bleeding from the gastrointestinal tract, intestinal atony, simultaneous administration of antitoxic drugs, the effect of which develops after absorption (methionine and others).

Side Effects

Dyspepsia, constipation or diarrhea, dark coloration of stool. With long-term use (more than 14 days), the absorption of vitamins, calcium and other nutrients from the gastrointestinal tract may be reduced.

Interaction

Reduces the absorption and effectiveness of concomitantly taken medications.

Storage conditions

In a dry place at a temperature not exceeding 25 °C.
Keep out of the reach of children.

Shelf life

3 years.

Manufacturer

Update of PFC JSC, Russia